Five Prime Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
The Week In Charts: How Much To “Invest?”
Video By: Dave Landry
Friday, July 10, 2020 3:00 PM EDT
In this episode, Dave Landry answers the question: "how much should you invest in the markets?"
In this video: APT, SPX, FPRX, VERI
Watch
3 Small Cap Biotechs With Upcoming Catalysts
Article By: Scott Matusow
Monday, October 1, 2018 8:21 PM EDT
Catalyst Trading in biotech stocks can be very profitable. Often times, many catalyst events are over looked by the market, especially when it comes to small cap biotech.
In this article: AFMD, BLRX, SNDX Also: BMY, FPRX
Read
Morning Call For Wednesday, Jan 24
Article By: Jim Van Meerten
Wednesday, January 24, 2018 9:42 AM EDT
Mar E-mini S&Ps (ESH18 +0.20%) this morning are up +0.13% at a new record nearest-futures high after U.S. Treasury Secretary Mnuchin endorsed a plunge in the dollar index to a 3-year low.
In this article: COF, MCK, TK, TSS, TXN, UAL, BOLD, ARAY, CERS, MRCY, QGEN, SIRI, PBYI, FPRX, AERI, RCKT
Read
Wells Fargo Says Buy Micro-Cap Drugmaker Ahead Of Cancer Immunotherapy Meeting
Article By: The Fly
Thursday, October 12, 2017 12:31 PM EDT
Shares of Infinity Pharmaceuticals are on the rise after Wells Fargo analyst Jim Birchenough upgraded the stock to a buy-equivalent rating.
In this article: INFI Also: FPRX
Read
Calithera Pharma In Focus, Part 3 - Arginase Inhibitor And Acquisition Target
Article By: Scott Matusow
Monday, January 9, 2017 7:51 AM EDT
In the last part of our series on Calithera Biosciences we will be examining the company's second clinical asset and its acquisition chances sometime this year or early 2018.
In this article: CALA Also: GILD, BMY, AMGN, FPRX, AFMD
Read

PARTNER HEADLINES

Latest Tweets for $FPRX

No tweets yet!